Skip to main content
Richard  Emsley

Professor Richard Emsley

Academic Director of the King’s Clinical Trials Unit

  • Professor of Medical Statistics and Trials Methodology

Biography

Richard Emsley holds a joint appointment as Academic Director of the King’s Clinical Trials Unit and Professor of Medical Statistics and Trials Methodology in the Department of Biostatistics & Health Informatics in the Institute of Psychiatry, Psychology & Neuroscience at King's College London. He was an NIHR Research Professor from 2019 to 2025.

He is the Theme Lead for Trials, Genomics and Prediction at the NIHR Maudsley Biomedical Research Centre and Director of the NIHR Research Support Service Hub delivered by King’s College London and Partners, which has a specific Hub focus on Mental Health & Neuroscience studies. He is the Director of the Innovative Trials Hub in the Data and Digital Alliance Team, as part of the Office for Life Sciences Mental Health Goals Programme.

Before joining the IoPPN in January 2018, Richard held a personal Chair at The University of Manchester as Professor of Medical Statistics and was Deputy Director of the then Manchester Clinical Trials Unit.

Richard studied at The University of Manchester for a BSc in Mathematics and a PhD in Biostatistics under the supervision of Professor Graham Dunn and Professor Andrew Pickles. Following his PhD, he worked as a Research Associate in the Centre for Biostatistics, and was awarded personal fellowships including an MRC Career Development Award in Biostatistics and an MRC Early Career Centenary Award, before being appointed as a Lecturer in 2012, and promoted to Senior Lecturer in 2015 and Professor in 2016.

Research interests

  • Clinical trials methodology
  • Design and analysis of efficient trials
  • Developing statistical methods for efficacy and mechanisms evaluation using causal inference approaches
  • Clinical trials in mental health and neuroscience

Education

On the MSc in Applied Statistical Modelling and Health Informatics, Richard contributes to the following modules:

  • Multilevel and Longitudinal Modelling (module lead)
  • Causal Modelling and Evaluation
  • Research Project

Expertise and public engagement

  • Member of funding committees for NIHR and Cancer Research UK
  • Investigator on the MRC-NIHR Trials Methodology Research Partnership, and co-lead of its Statistical Analysis Working Group.
  • Chair of the Scientific Committee for the International Clinical Trials Methodology Conference 2026
  • Lead for the joint department and NIHR Maudsley BRC Methodology Patient and Public Involvement group

    Research

    avatar logo
    AVATAR2

    AVATAR therapy offers a new approach to working with distressing voices (auditory hallucinations), using digital technology to allow ‘face-to-face’ dialogue between the voice-hearer and a computerised representation of their voice (the avatar). We are now taking this forward in the AVATAR2 trial.

    AVATAR_head_only_large
    The Avatar Project

    The AVATAR Project was a clinical research trial of an innovative new therapeutic treatment designed to help people suffering from distressing voices.

    Project status: Completed

    People walking
    Mental Health & Neuroscience Clinical Trial Statistics Group

    The Mental Health & Neuroscience Clinical Trial Statistics Group leads on the design, conduct and reporting of clinical trials in mental health.

    trials-methodology-research-group-cropped-1903x558
    Trials Methodology Research Group

    The Trials Methodology Research Group is focussed on improving the design, conduct and analysis of clinical trials for the benefit of participants, researchers, and others who use the evidence to make decisions about healthcare.

    Atlantis - 400dpiLogo
    ATLANTIS - AnTiconvuLsant AugmeNtation Trial In Schizophrenia

    NIHR funded multi-centre clinical trial evaluating valproate augmentation of antipsychotic medication in the management of psychosis

    spilled-medication
    STOP-D (Sertraline TO prevent Post-TBI Depression)

    A multi-centre placebo-controlled double blind RCT to investigate the use of sertraline in reducing depressive symptoms in traumatic brain injury patients.

    Project status: Ongoing

    ARTICLE Molecule Model
    Causal Analysis & Evaluation

    The Causal Modelling Group comprises statisticians and methodologists at King’s College London interested in drawing causal inferences from study data.

    ICALD Thumbnail
    Improving Communication with Adults with Learning Disabilities

    Improving Communication with Adults with Learning Disabilities is a five-year programme led by Vicky Slonims and Martin Knapp aimed at improving communication with adults with learning disabilities in social care settings.

    News

    New funding for UK mental health research in under-served areas

    The NIHR is investing almost £55 million in five additional Mental Health Research Groups (MHRGs). King’s College London researchers will collaborate on three...

    Blackpool high street

    King's plays major role in £50 million government funded programme into mental health research

    Researchers at King's, University of Oxford and Cardiff University will help transform mental health data, clinical trials and industry partnerships as part...

    IoPPN signage

    Nearly £5m Wellcome funding to improve access to psychological therapies for young people with psychosis and depression using AI

    Researchers have received £4.9 million to develop and evaluate an AI-supported intervention for cognitive difficulties in young people with psychosis and...

    Illustration of man seated in arm chair speaking to therapist on mobile phone

    Mollie Payne awarded the Society for Clinical Trials Thomas C. Chalmers Student Scholarship

    Mollie Payne wins the Thomas C. Chalmers Student Scholarship at the 2025 Society for Clinical Trials Annual Meeting in Vancouver, Canada.

    Three people stood in front of blue curtain next to lectern

    Multi-site trial uses digital avatars to effectively reduce distressing voices in psychosis

    A novel therapy using computer-generated avatars has found to be an effective way of helping people with psychosis reduce the distress and frequency with...

    Person points at a laptop screen with AVATAR therapy icons displayed on it

    New NIHR Research Support Service established at King's College London

    The National Institute of Health and Care Research (NIHR) has awarded £6.8 million to King’s College London to establish a new Research Support Service that...

    NIHR Research Support

    Events

    06Nov

    Trials Methodology Research Showcase

    The Trials Methodology Research Showcase is a key opportunity to find out more about the wide-ranging research undertaken by our team of trial methodologists...

    Please note: this event has passed.

    Features

    Behind the scenes: IoPPN at the International Clinical Trial Methodology Conference

    Dr Merry Martyn and Dr Anca Chis Ster from the Department of Biostatistics & Health Informatics take us behind the scenes of the International Clinical Trial...

    ICTMC Edinburgh

    Spotlight

    Talking back: the power of digital avatars in psychosis therapy

    AVATAR therapy has shown significant promise in reducing the frequency and impact of distressing voices for those with a diagnosis of schizophrenia. Working...

    Avatar 007

      Research

      avatar logo
      AVATAR2

      AVATAR therapy offers a new approach to working with distressing voices (auditory hallucinations), using digital technology to allow ‘face-to-face’ dialogue between the voice-hearer and a computerised representation of their voice (the avatar). We are now taking this forward in the AVATAR2 trial.

      AVATAR_head_only_large
      The Avatar Project

      The AVATAR Project was a clinical research trial of an innovative new therapeutic treatment designed to help people suffering from distressing voices.

      Project status: Completed

      People walking
      Mental Health & Neuroscience Clinical Trial Statistics Group

      The Mental Health & Neuroscience Clinical Trial Statistics Group leads on the design, conduct and reporting of clinical trials in mental health.

      trials-methodology-research-group-cropped-1903x558
      Trials Methodology Research Group

      The Trials Methodology Research Group is focussed on improving the design, conduct and analysis of clinical trials for the benefit of participants, researchers, and others who use the evidence to make decisions about healthcare.

      Atlantis - 400dpiLogo
      ATLANTIS - AnTiconvuLsant AugmeNtation Trial In Schizophrenia

      NIHR funded multi-centre clinical trial evaluating valproate augmentation of antipsychotic medication in the management of psychosis

      spilled-medication
      STOP-D (Sertraline TO prevent Post-TBI Depression)

      A multi-centre placebo-controlled double blind RCT to investigate the use of sertraline in reducing depressive symptoms in traumatic brain injury patients.

      Project status: Ongoing

      ARTICLE Molecule Model
      Causal Analysis & Evaluation

      The Causal Modelling Group comprises statisticians and methodologists at King’s College London interested in drawing causal inferences from study data.

      ICALD Thumbnail
      Improving Communication with Adults with Learning Disabilities

      Improving Communication with Adults with Learning Disabilities is a five-year programme led by Vicky Slonims and Martin Knapp aimed at improving communication with adults with learning disabilities in social care settings.

      News

      New funding for UK mental health research in under-served areas

      The NIHR is investing almost £55 million in five additional Mental Health Research Groups (MHRGs). King’s College London researchers will collaborate on three...

      Blackpool high street

      King's plays major role in £50 million government funded programme into mental health research

      Researchers at King's, University of Oxford and Cardiff University will help transform mental health data, clinical trials and industry partnerships as part...

      IoPPN signage

      Nearly £5m Wellcome funding to improve access to psychological therapies for young people with psychosis and depression using AI

      Researchers have received £4.9 million to develop and evaluate an AI-supported intervention for cognitive difficulties in young people with psychosis and...

      Illustration of man seated in arm chair speaking to therapist on mobile phone

      Mollie Payne awarded the Society for Clinical Trials Thomas C. Chalmers Student Scholarship

      Mollie Payne wins the Thomas C. Chalmers Student Scholarship at the 2025 Society for Clinical Trials Annual Meeting in Vancouver, Canada.

      Three people stood in front of blue curtain next to lectern

      Multi-site trial uses digital avatars to effectively reduce distressing voices in psychosis

      A novel therapy using computer-generated avatars has found to be an effective way of helping people with psychosis reduce the distress and frequency with...

      Person points at a laptop screen with AVATAR therapy icons displayed on it

      New NIHR Research Support Service established at King's College London

      The National Institute of Health and Care Research (NIHR) has awarded £6.8 million to King’s College London to establish a new Research Support Service that...

      NIHR Research Support

      Events

      06Nov

      Trials Methodology Research Showcase

      The Trials Methodology Research Showcase is a key opportunity to find out more about the wide-ranging research undertaken by our team of trial methodologists...

      Please note: this event has passed.

      Features

      Behind the scenes: IoPPN at the International Clinical Trial Methodology Conference

      Dr Merry Martyn and Dr Anca Chis Ster from the Department of Biostatistics & Health Informatics take us behind the scenes of the International Clinical Trial...

      ICTMC Edinburgh

      Spotlight

      Talking back: the power of digital avatars in psychosis therapy

      AVATAR therapy has shown significant promise in reducing the frequency and impact of distressing voices for those with a diagnosis of schizophrenia. Working...

      Avatar 007